Natural killer cells in clinical development as non-engineered, engineered, and combination therapiesNina Lamers-Kok, Monica Raimo, Denise Panella et al.|Journal of Hematology & Oncology|2022Cited by 178
Performance of the ABCD-GENE Score for Predicting Clinical Outcomes in Clopidogrel-Treated Patients with ACSYing Jin, Ping Ye, Jing Ma et al.|Journal of Cardiovascular Translational Research|2022Cited by 6
Efficacy and Safety of Antithrombotic Therapy With Oral Anticoagulants in Real-World Elderly Patients With Acute Coronary Syndrome and Atrial FibrillationYangxun Wu, Tong Yin, Haiping Liu et al.|Frontiers in Cardiovascular Medicine|2022Cited by 6
Prediction of residual ischemic risk in ticagrelor-treated patients with acute coronary syndromeYuting Zou, Tong Yin, Yuyan Wang et al.|Thrombosis Journal|2022Cited by 5
Additional file 1 of Natural killer cells in clinical development as non-engineered, engineered, and combination therapiesNina Lamers-Kok, Monica Raimo, Denise Panella et al.|Figshare|2022Cited by 0